ASCO Advocates for Boosting NIH and FDA Budgets to Continue to Increase...
On November 20, ASCO sent two letters to U.S. House and Senate Appropriations Committee members advocating for robust funding for two government agencies that have significant influence on cancer...
View ArticleASCO’s Chief Medical Officer Authors a Featured Post on Federal Research...
On November 24, ASCO Chief Medical Officer Richard Schilsky, MD, FACP, FASCO, was a guest commentator on Research!America’s Blog. Research!America is the nation’s largest not-for-profit public...
View ArticleASCO President Calls for Greater Funding for NIH and NCI in Op-Ed in Capitol...
On November 27, ASCO President Julie Vose, MD, MBA, FASCO, had an op-ed published in The Hill calling on Congress to reinvest in federal research. Dr. Vose’s piece, “It’s Time for Congress to Reinvest...
View ArticleCongress Has Until December 16 to Pass Fiscal Year 2016 Spending Legislation
On December 11, the U.S. House of Representatives passed a five-day continuing resolution (CR) for funding the federal government (the Senate passed the CR on December 10). Lawmakers now have until...
View ArticleA Banner Year for Moving ASCO Policy and Practice Agenda Forward
During the past 12 months, an extraordinary level of activity and progress occurred in cancer-related policy and practice activities. From physician reimbursement and federal research funding to...
View ArticleASCO Supports Research Funding Levels in Omnibus Spending Bill
On December 15, U.S. House of Representatives leaders unveiled an omnibus spending bill that will fund the federal government through Fiscal Year 2016 (FY2016). ASCO strongly supports the significant...
View ArticleIncreased Funding For NIH – A Hard-earned Victory for ASCO’s Advocacy Community
On December 18, Congress passed a spending bill for fiscal year 2016 (FY2016) that included the largest increase in annual funding for the National Institutes of Health (NIH) in over a decade. This...
View ArticleDecline in Cancer Deaths Result of Decades of Advancing Cancer Care
Statement from American Society of Clinical Oncology (ASCO) President Julie M. Vose, MD, MBA, FASCOOn January 7, the American Cancer Society issued a report showing a 23 percent decline in cancer death...
View ArticleClik here to view.
ASCO Names Cancer Advance of the Year
New Report Examines Recent Progress Against Cancer, Underscores Payoff of Nation's Investment in Cancer ResearchAt a Capitol Hill briefing on Feb. 4, 2016, the American Society of Clinical Oncology...
View ArticlePresident’s Budget a Stunning Jumpstart to “Moonshot” Initiative, Sustained...
Statement by ASCO President Julie M. Vose, MD, MBA, FASCOBy making the “moonshot” initiative a centerpiece of his FY 2017 budget proposal, President Obama has taken a critical step in aligning the...
View Article
